• First AI Antibody In Humans with Aulos' Aron Knickerbocker

  • Jul 15 2024
  • Duración: 1 h y 9 m
  • Podcast

First AI Antibody In Humans with Aulos' Aron Knickerbocker  Por  arte de portada

First AI Antibody In Humans with Aulos' Aron Knickerbocker

  • Resumen

  • We love to hear from our listeners. Send us a message.

    Data drives decision-making at Aulos Bioscience. It's also driven the career trajectory of its CEO. On this week's episode of the Business of Biotech podcast, we get an introspective walk through Aron Kinickerbocker's strategically-orchestrated career path, from his early days in the labs at Bristol-Myers Squibb and Genentech to his leadership of Aulos Bioscience, a company that boasts the first AI-generated antibody in human clinical trials. We explore Aulos' innovative IL-2 antibody and the role AI played in its highly-targeted and toxicity-reducing design, and we do it in pragmatic fashion Aron's not about the AI hype, he's about the AI data and in its Phase 1/2 clinical trial, the data is looking pretty good.

    Register for Bioprocess Online’s Bio Expo Live, being held July 30th through August 1st . This inaugural expo is a fantastic opportunity for biopharma companies and contract manufacturers to evaluate the latest and greatest from the comfort of your desktop or mobile device. Conveniently, we’ve broken down the lineup into Upstream Solutions July 30th, Downstream Solutions July 31st, and Quality, Analytical, and Data Solutions August 1st. It’s absolutely free to register for this series of short, digestible, and interactive sessions -- just hit the links above to register for Bio Expo Live today!


    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre First AI Antibody In Humans with Aulos' Aron Knickerbocker

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.